Agenda
TUESDAY, MAY 21, 2024
- 09:30 - 09:45 | Welcome by Conference Chairpersons
- 09:45 - 10:15 | Plenary: Dr. Anula Jayasuriya, MD, PhD, Partner, Kidron Capital Assets
- 10:15 - 10:45 | Plenary: Aharon (Ronny) Gal, PhD, Chief Strategy & Growth Officer, Member of the Executive Committee, Novartis, Five thoughts about the future of the pharmaceutical industry
- 10:45 - 11:15 | Plenary: Gil Bar-Nahum, PhD, Managing Director, Jefferies International
- 11:15 - 11:45 | Coffee Break
HALL A
11:45 - 13:45
Why does cardiovascular disease remain the number ONE target for MedTech innovation?
Moderators: Dr. David Israeli, MD, Chairman & CEO, Magenta Medical,
Amir Gross, Co-Founder & CEO, Cardiovalve
Keynote: Doron Harlev, Co-Founder & CEO, Affera, “The Affera story – from an electrophysiology startup to a market-disrupting technology”
Keynote: Beni Surpin, Partner, Goodwin Procter LLP. “The Secret Recipe to Mega Success in the Cardiovascular MedTech Space – From a Legal Perspective”
Company Presenters:
Dr. David Israeli, MD, Chairman & CEO, Magenta Medical, “Magenta Elevate: High-Output, Low French Size Percutaneous Mechanical Circulatory Support”
Ronen Eckhouse, CEO, Rapid Medical Ltd. “Rapid Medical is Expanding What’s Possible in Stroke Treatment”
Amir Danino, Founder & CEO, Innoventric, “Innoventric Heterotopic Cross-Caval Portfolio”
Rafi Benary, Co-founder and CTO, Althea Medical, “The Friendly Giant: Opportunities for Althea Medical’s Pulmonary Embolectomy Solutions”
Boaz Manash, CEO, Cardiac Success, ” Vsling: Transcatheter Ventricular Repair Device for Heart Failure Patients”
Prof. Haim Danenberg, MD, CMO, Append Medical, “Advancements in Left Atrial Appendage (LAA) Elimination: Introducing a next generation for LAA exclusion”
Eyal Baror, CEO, Innovalve, “Innovalve TWIST Technology:A Novel Approach to TranscatheterMitral Valve Replacement Challenges”
HALL B
11:45 - 13:45
Evolving trends in Cancer Therapeutics
Moderator: Tehila Ben Moshe, PhD, Founder, CEO & Chairman, Biond Biologics
Keynote: Prof. Ido Amit, Department of Immunology, Weizmann Institute of Science, “The power of ONE: Immunology in the age of spatial and single cell genomics”
Keynote: Michael A. Margolis, Head of Healthcare Life Sciences, Co-Head of Health, Oppenheimer, “Current trends & what’s hot in the Cancer Therapeutics space from a capital markets and M&A perspective”
Company Presenters:
Irit Carmi-Levy, General Manager & CSO, Aummune Tech, “A new class of individualized immunotherapy to treat solid tumors”
Pini Tsukerman, CSO, Nectin TX, “Pushing the Boundaries of Cancer Immunotherapy with Novel Targets, and Therapeutic Approaches”
Yaron Pereg, CEO, KAHR Medical Ltd, “DSP107 – Combining Innate and Adaptive Immunity to Enhance Efficacy in Solid and Hematological Malignancies”
Motti Hakim, PhD, VP R&D, Biond Biologics,
Peleg Rider, PhD, Co-Founder & VP of Immunology, Gilboa Therapeutics, “SolidT, a platform technology for targeting solid tumors with safer and more “
Prof. Amnon Peled, CSO, AlonBio, “Targeting migration, survival and immune response pathways in cancer”
Sigal Kalmanson Cusnir, CEO, Starget Pharma, “Peptide Radioligand Therapy, The New Wave of Cancer Warheads”
HALL C
11:45 - 13:45
Unlocking a new era of brain health innovation
Michel Habib, Co-Founder, Managing General Partner, ALIVE Israel HealthTech Fund
Alon Ben Noon, CEO, NeuroSense Therapeutics, “PrimeC As a Promising Therapeutic Candidate for ALS”
Iftal Dolev, PhD, CEO, QuantalX Neurosciences, “Delphi- MD Brain Health Diagnosis at Any Point-of-Care”
- 13:45 - 15:00 | Lunch
HALL A
15:00 - 17:00
Digital Biomarkers & Digital Pathology: new tools to enhance therapy
Moderator: Avi Veidman, Co-Founder & CEO, Nucleai
Keynote: Dr. Iris Barshack, MD, Head of Pathology Institute, Chair of the Israeli Association of Pathologists, Sheba Medical Center, “Innovation in digital pathology for clinical practice”
Company Presenters:
Boaz Brill, PhD, Pentaomix, Co-Founder &CEO, “Multiplex Imaging for Better Cancer Diagnosis“
Danit Oz Levi, PhD, Head of Scientific & Clinical Affairs,Imagene, “How can Immediate Oncology Intelligence Guide Patients’ Optimal Cancer Treatment?”
Issar Yazbin, VP Product Manager, Ibex Medical Analytics, “Impacting Patient Outcomes with Trusted Cancer Diagnostics”
Dr. Amy Meitus, MD, Scopio Labs, “Revolutionizing first line hematology testing with Full Field technology”
Gabe Siegel, Founder & CEO, Augmentiqs, “What’s slowing down digital pathology? ”
Tuvik Beker, PhD, Pangea Biomed, “Inferring gene expression from slide images can be used to predict treatment outcomes”
Michele Bentata, Pharma Business Development, Owkin, “Digital Biomarkers & Digital Pathology:New tools to enhance therapy”
HALL B
15:00 - 17:00
Next generation of genetic medicine
Moderators: Yael Gruenbaum Cohen, DMD, PhD, Venture Partner & Head, aMoon Velocity & aMoon Alpha
Prof. Yaniv Erlich, CEO & Co-Founder, Eleven Therapeutics
Keynote: Prof. Adi Barzel, Associate Professor, School of Neurobiology, Biochemistry & Biophysics, Faculty of Life Sciences, Tel Aviv University
Company Presenters:
Nir Skalka, PhD, CSO, Circuit Bio, “Cancer immunotherapy using highly selective gene circuits”
Ram Waisbourd, CEO, Trojan Cells, “Trojan Cells : A New Cell Therapy Modality for Targeted Production of Therapeutics in a Disease Microenvironment”
Yogev Debbi, CEO, Mana.bio, “Utilizing Machine Learning Approach to Unlock Extra-Hepatic Delivery of Lipids Nanoparticles”
Efrat Ozeri Galai, PhD, VP Research , SpliSense, “SpliSense – RNA Based Platform for Pulmonary Diseases”
Roee Farber, PhD, CEO, ZipBio, “ZipBio: Compressing biology to develop the next generation of gene therapies”
Prof. Yuval Tabach, Co-Founder, Professor, The Deep Genomic Laboratory, Hebrew University medical school, Department of Developmental Biology & Cancer Research,
“The Genomic Revolution – Evolution, Data and Treatment”
Yair Benita, PhD, CTO, AION Labs,
HALL C
15:00 - 17:00
What can we do to make healthier aging a reality?
Moderator: Prof. Varda Shalev, MD, MPA, Managing Partner, Team8 Health
Keynote: Dr. Josef Coresh, MD, PhD, Founding Director, Optimal Aging Institute, Professor of Population Health and Medicine, NYU Grossman School of Medicine, ” Vascular health: A proven target and enormous opportunity for healthy aging”
This keynote will be a “fireside chat” format led by Prof. Varda Shalev, a family physician with over 30 years of experience. It will feature Prof. Naama Sabar-Ben Yehoshua, an inspiring 85-year-old advocate for healthier aging, and her son, Dr. Ron Sabar, founder and CMO of Sabar Health. They will discuss their perspectives on aging from both medical and personal viewpoints.
Company Presenters:
Rotem Bar-Or, PhD, Head, Academic Partnerships & IP, NeuraLight, “Early Detection, Better Protection: Using Apps to Identify Neurological Diseases in Aging”
Rami Kirshblum, Co-Founder & CEO, Uniper Care, “Connecting the Ages: Enhancing Elderly Social Engagement Through Technology”
Sheli Bekel Sela, VP R&D, SensiAI
Eyal Lewin, CEO, NYX Technologies, “Dreaming of Youth: Personalized Sleep Therapies for Better Aging”
Dr. Hilla Ben Pazi, MD, CEO, Avertto, “Guarding the Future: Advanced Stroke Prevention and Monitoring for Aging Populations”
Tal Shapsa Heiman, Co-Founder & CEO, Epilog, “Navigating Life’s Twilights: Personalized Companionship for Serious Illness Management “
Rachel Yarconi, Founder & CEO, MyAir, “Breathe Easy: Personalized Nutrition for Stress-Free Aging”
Daniel Tal Mor, Co-Founder & CEO, Lumen.me,“Lumen: Metabolism Tracker to help you optimize your metabolism, energy, and overall well aging”
WEDNESDAY, MAY 22, 2024
- 09:30 - 09:50 |Plenary: Dror Bin, Chief Executive Officer, Israel Innovation Authority, "Challenges Breed Innovation"
- 09:50 -10:20 |Plenary: Richard Francis, President and Chief Executive Officer, Teva Pharmaceuticals, "Serving patients in Israel and around the World"
- 10:20 - 10:50 |Plenary: Dr. Boaz Hirshberg, MD, Senior Vice President, Clinical Sciences General Medicine, Regeneron Pharmaceuticals
- 10:50 - 11:20 | Coffee Break
HALL A
11:20 - 13:20
Liquid biopsy & Diagnostics: Getting closer to transforming early detection and disease management
Moderators:
Dr. Ofer Sharon, MD, CEO, OncoHost
Yaron Daniely, PhD, General Partner, aMoon
Keynote: Stanley Lapidus, Inventor & Entrepreneur, Founding CEO, Cytyc Corp., ThinPrep & EXACT Sciences, “Clinical trials for liquid biopsy”
Company Presenters:
Prof. Tomer Shlomi, MetaSight, “Population-scale molecular diagnostics”
Michal Mark Danieli, PhD, Founder & CEO, Early Labs, “When AI meets AI (Animal Intelligence) – A Urine Test for Early Detection of Lung Cancer”.
Dr. Aharona Shuali, MD, VP Medical, Nucleix, “Bringing liquid biopsy to early detection of cancer-Nucleix’ journey”
Inbal Zafir-Lavie, PhD, CEO & Co-Founder, NEVIA,“The potential of vaginal secretions: redefining women’s liquid biopsy”
Dr. Ofer Sharon, MD, CEO, OncoHost, “The PROphet Liquid Biopsy Platform”
Vered Bar, PhD, VP R&D, CureResponse Tech, “Optimizing Anticancer Treatment Management with a Functional Patient Derived Explants (PDE) Assay”
Olga Nissan, PhD, Co-Founder & CEO, Protica Bio, “Predicting Cancer Immunotherapy Response with AI-Enhanced Proteomics”
HALL B
11:20 - 13:20
'MedTech Is Accelerating – Trends and Focus Area'
Moderators:
Gilad Glick, VP, JJDC Medtech, Johnson & Johnson Innovation Fund, “MedTech Acquisitions – Is commercialization the new expectation ?”
Eyal Lifschitz, General Partner & Co-Founder, Peregrine Ventures
Ronen Segal, CTO, Alpha Tau Medical,
“Fighting Cancer Goes Nuclear – What makes Alpha Tau’s novel treatment most promising in the booming market of Radioisotope treatments ?”
Benny Dilmoney, CEO & Founder, Magneto Thrombectomy Solutions, “The Magneto eTrieve Technology: A System for Mechanical-Electric Thrombectomy”
Ilan Uchitel, CEO & Co-Founder, CAPS Medical, “Revolution in Oncology : Transforming Minimally Invasive Treatments for Solid Tumors”
Ron Aginsky, Co-Founder & President, FUSMobile, “Treating Pain Without the Pain”
Yuval Mandelbaum, CEO, Discure Technologies, “Reversing Degenerative Disc Disease”
Hadar Levy, CEO, BrainsWay, Do we Know Enough About BrainsWay transform for future growth?
Arik Ben Ishay, CEO, BioBeat Technologies, “Cuffless Blood-Pressure Monitoring”
HALL C
11:20 - 13:20
Is AI revolutionizing drug discovery and clinical development?
Moderators:
Anat Cohen Dayag, PhD, President & CEO, Compugen
Dan Goldstaub, PhD, Scientific Co-Founder, Phase V
Keynote: Dr. Eric A. Hughes, MD, PhD, Executive Vice President, Global R&D & Chief Medical Officer, Teva Pharmaceuticals, “AI-Powered Innovation: How AI Aligns with Pharma’s R&D Strategy”
Keynote: Guy Hadari, PhD, SVP, Global CIO, Biogen, “AI-Powered Innovation: The tools and process needed for successful integration in Product development”
Company Presenters:
Eran Ophir, PhD, CSO, Compugen, “From Code to Cure: Compugen advances the next generation of cancer immunotherapies”
Raviv Pryluk, PhD, CEO, Phase V, “Adaptive Clinical Trials and Tools to Support Them”
Oshrat Kfir, VP Product Management, CytoReason,
” Managing your drug portfolio with an AI platform and computational disease model”
Tali Raveh-Sadka, PhD, VP of R&D, Immunai, “Harnessing immunomics to improve therapeutic decision making”
Isaac Bentwich, CEO, Quris AI, “Quris-AI”
Yanay Ofran, PhD, Founder & CEO, Biolojic Design, “AI-based design of functional therapeutic bodies”
Yochi Slonim, Co-Founder & CEO, Anima, “LightON RNA: Bringing AI to mRNA Biology to transform disease understanding and drug discovery”
- 13:20 - 14:30 | Lunch
HALL A
14:30 - 16:30
“NUTRItech” is the name of the game"
Moderator:
Tammy Meiron, PhD, Fresh Start FoodTech Incubator
Keynote: Prof. Uri Lesmes, Associate Professor, Technion – Israel Institute of Technology, “The effect of nutrients on our body – an
updated point of view”
Company Presenters:
Zohar Gavish, PhD, Founder & CEO, Gavish Research Services, “Getting Practical:
The Fate of Nutracueticals/Bioactives in Our Body – Histological Point of View”
Yochi Hagay, PhD, Co-Founder & CTO, Bio-Harvest Sciences, “VINIA, the first Botanical Synthesis based product from BioHarvest, improves vascular function, blood flow & diabetic parameters”
Zakhar (Zacki) Nudelman, PhD, Chief Business Officer & Director of Scientific Affairs,
SOLVEAT, “Food as Medicine: The Industrial Frontier of Herbal Remedies”
Yael Kuperman, PhD, Co-Founder & CTO, ANeustart, “Feed your brain: is there a
place for a nutrient-based therapy for autism”
David Gordon, Strategic Advisor, MakeSense Digital Health, “The Diet Data Revolution: Finally, a Truely Automated Meal & Snack Logging System for Obesity and Diabetes Management”
HALL B
14:30 - 16:30
The heart, the liver, and the brain in concert: a year of revolutions in the cardiometabolic space
Moderator:
Iris Grossman, PhD, CThO, Eleven Therapeutics
Dr. Boaz Hirshberg, MD, Senior Vice President, Clinical Sciences General Medicine, Regeneron Pharmaceuticals
Opening: Iris Grossman, PhD, CThO, Eleven Therapeutics
Keynote: Dr. Mitchell Steiner , M.D., F.A.C.S., Chairman, President, & Chief Executive Officer, Veru Inc, “Make GLP-1 weight loss drugs more effective and precise — get greater fat loss by preserving muscle mass and function”
Keynote: Ram Weissbourd, ex-COO/CBO, 89Bio, “Dawn of a New Era in the Treatment of Fatty Liver Disease”
Keynote: Prof. Yossi Tam, Professor, School of Pharmacy, Institute for Drug Research, The Hebrew University of Jerusalem, Center for Nanoscience & Nanotechnology, “From Disappointment to Triumph: Cannabinoids’ Resurgence in Metabolic Syndrome Treatment”
Panel discussion, moderated by Dr. Boaz Hirshberg, MD, Senior Vice President, Clinical Sciences General Medicine, Regeneron Pharmaceuticals:
Adi Mor, PhD, CEO, Chief Scientific Officer and Co-Founder, Chemomab, “Pioneering Innovative Treatments for Inflammatory-Fibrotic Diseases”
Kfir Umansky, PhD, Co-Founder, Head of R&D, Principal Investigator, Velakor, “Velakor- using lessons from neonatal cardiac regeneration to repair the broken heart”
Prof. Moshe Mittelman, CSO, Cannalean Biotechs, “Attacking World Enemy – Lowering Lipids”
Maya Cohn Adulamy, Executive Director, Innovation & Head of Israel, Valo, “Reimagining Cardiovascular drug discovery and clinical diagnostics with real-world Data”
Eran Blaugrund, PhD, VP R&D, Raziel Therapeutics, “A novel small molecule, RZL-012, for focal fat reduction”
Closing by Moderators
HALL C
14:30 - 16:30
Women’s Health: Cutting-edge innovation to tackle collective pain points
Moderators:
Avital Adler, PhD, Principal, aMoon Edge
Inbal Zafir Lavie, PhD, CEO & Co-founder, NEVIA
Keynote: Dr. Anula Jayasuriya, MD, PhD, Co-Founder and Managing Director, Kidron Capital Assets, “Women’s health: from niche to WOW!”
Keynote: Stanley Lapidus, Inventor & Entrepreneur, Board Chairman & Board Member, Founding CEO, Cytyc Corp., ThinPrep & EXACT Sciences, “Among the greatest triumphs in women’s health: The pap test and mammography”
Company Presenters:
Miriam Oron, PhD, CEO & Co-Founder, DermAb.io, “Connecting the Dots: Skin Biomarkers, Women’s Physiology, and Autoimmune Diseases”
Shlomit Steinberg-Koch, CEO & Co-Founder, Predicta Med, “Revolutionizing autoimmune diseases diagnosis & treatment using AI “
Gali Lerman, PhD, CSO, TAU – Colton Center for Autoimmunity
Manuela Vecsler, PhD, VP Clinical & Scientific Affairs, Ibex Medical Analytics, ” AI in Breast Cancer Diagnosis: from Machine Learning to LIVE Worldwide Clinical Use”
Hadas Ziso, PhD, CEO & Co-Founder, EndoCure, “Robotic AI-powered high-resolution ultrasound imaging for superior endometriosis diagnosis and management”
Dr. David Shashar, MD, CEO & Co-Founder, PregnanTech, “PregnanTech: A game-changing device revolutionizing preterm birth prevention”
Daniella Gilboa, CEO & Co-Founder, AIVF, ” AIVF: Elevating IVF to new horizons: The dawn of AI enhanced IVF care”
THURSDAY, MAY 23, 2024
- 10:00 - 10:30 - Plenary: Prof. Yitshak Kreiss, M.D.,Director General, Sheba Medical Center, "Reimagining healthcare for sustainable future: The new role of healthcare leaders"
- 10:30 - 11:00 - Plenary: Prof. Itzhak Fried, MD., PhD, member of Israel Academy of Science and Humanities, Prof. Of Neurosurgery and Psychiatry at UCLA and Prof.of Neurosurgery at Tel Aviv University, "Reengineering of the human brain: bio-chips and the future of neurotechnology"
- 11:00 - 11:30 - Coffee Break
HALL A
11:30 - 13:30
Advancements in the space of bio-convergence
Moderator:
Aviv Zeevi, PhD, VP, Head of Technological Infrastructure Division, Israeli Innovation Authority
Panel A
From the pollen to the plant:
Biopharming and Integrated Technologies for Agriculture and the World of Health
Inbar Maymon Pomeranchik, CEO, AgChimedes
Prof. Oded Shoseyov, PI & Serial Entrepernuer, CollPlant
Dganit Vered, CEO, Smart Agro Fund
Michal Levi, PhD, Chief Scientist, Senior Deputy Director General, Ministry of Agriculture and Rural Development
Eytan Schwartz, VP Global Strategy, BeeHero
Panel B
A computational tool for accelerated and smart development of biological technologies – shorten experiments and scan based on the composition of the genomes of non-chemical materials with similar performance. Is there a phase difference between the pharmaceutical world and agriculture?
David Zigdon, CEO, MIGAL Galilee Research Institute, “Infrastructure and research: working together”
Dotan Peleg, CEO, ProJini AgChemcompany, “ProJini AgChem”
Yuval Giladi, PhD, CEO & Co-Founder, FreezeM
Sharon Shacham, Co-Founder & Managing Partner, E44 Ventures, Founder at Karyopharm Therapeutics | Board Member | Climate Tech
Dr. Tamar Eigler, PhD, Co-founder & CTO, Profuse Technology, “From the lab to the plate – how the correct use of nutritional supplements and protocols increases the meal and reduces costs?”
Panel C
Work with expert R&D infrastructures – company and infrastructure complementary partners in groundbreaking research. Synthetic biology infrastructure and fermentation infrastructure as case studies
Moderator:
Aviv Zeevi, PhD, VP, Head of Technological Infrastructure Division, Israeli Innovation Authority
HALL B
11:30 - 13:30
Digital health role in 2024 and forward
Moderator:
Ittai Harel, Managing Partner, Pitango Venture Capital
Keynotes:
Amir Dan Rubin – CEO & Founding Managing Partner, ex One Medical CEO, Healthier Capital
Udi Goori, General Manager, Carelon Digital Platforms Israel, “The Health Plan Paradigm Shift: Enabling Proactive Healthcare”
Company Presenters:
Moran Snir, CEO &
Daniella Gilboa, Ceo & Co- Founder, AIVF, “Elevating IVF to new horizons: The dawn of AI enhanced IVF care”
Ronen Lavi, Co-Founder, Navina AI,
Dedi Gilad, Co-Founder, TytoCare, “Digital Health Growth Journey – the Tyto story”
Yoni Shtein, Co-Founder, Laguna, “Conversational AI in Healthcare”
Alon Joffe, Co-Founder, Eleos Health, “Eleos Health”
Gal Salomon, Chairman of the board, Clew Medical, “Clew Medical, From Clinical to ROI”
Discussion: Focus on business models; “what works and what does not”, learnings shared
HALL C
11:30 - 13:30
Hospital at home: universities ‘and hospitals’ innovations
Moderator:
Avner Halperin, CEO, Sheba Medical Center
Keynote: Dr. David M. Levine, MD,MPH, MA, Practicing General Internist & Clinician-investigator, Brigham Health & Harvard Medical School,
“Home Hospital: Expectations and Innovation”
Keynote:
Dr. Avi Tsur, MD, MBA
Medical Director ARC, Director of Obstetrics and Gynecology at Sheba Beyond, CMO, Shela Health, “Crisis and Opportunity: Redesigning the High Risk Pregnancy Journey with Hybrid Virtual Care”
Company Presenters:
Roni Attali, PhD, CEO, AISAP, “Empowering physicians with AI at the-point-of-care”
Ziv Peremen, PhD, CEO, Xtrodes, “Unleashing the full potential of Electrophisiological home monitoring”
Mira Altmark-Sofer, Vice President Marketing, Pulsenmore, “The intersection of digital health and prenatal care”
Tomer Epstein, Director, Strategic Partnerships, Biobeat, “Transforming mental health treatment with data from deep in the brain”
Avner Rouach, Founding Partner & CEO, CatAI, “CatAI”
Tal Or, Co-Founder, ATLASense Biomed Ltd, “REPHAEL – From Reactive to Proactive for better preventive”
HALL D
12:30 - 13:30
Workshop: Hogan Lovells: The promise and challenge of bringing medical technology products with Artificial Intelligence to market
- 13:30 - 14:30 - Lunch
HALL A
14:30 - 16:30
“From Local Successes to Systemic Scale - BioConvergence Infrastructure Enabling Growth”
Moderator: Nathalie Bloch, MD, 8400 Network Member, BioConvergence Committee Member
Keynote: Dr. Michal Tsur, Co-Founder & Co-CEO, Remepy, “Improving Patient Care with Hybrid Drugs”
Company Presenters:
Dr. Yishay Falick, MD, Director, HealthTech & Bioconvergence, Israeli Aerospace Industry (IAI), “BioConvergence Fueling Dual Use Technologies “
Dan Shimon, CEO, Pre-Cure “From Tumor on a Chip to Patient on a Chip – Transforming Drug Development”
Chat:
Orly Savion, PhD, Alagene , “The SynBio Opportunity”
Rachela Popvotzer, PhD, Vice Dean & Head of the Laboratory of Nano-Bioengineering, Bar Ilan University
Company Presenter:
Dror Baran, COO & Co-Founder, Enzymit, “Enzymit: The New Chemistry of Enzyme Design”
Company Presenter:
Oren Caspi, PhD, Director of the Heart Failure Unit, Head of “Rambam’s Cardiovascular Research and Innovation Center, Bioconvergence Platforms based on Human Cardiovascular Organoids for Modelling and Preventing Chemotherapy-induced Cardiomyopathy”
Prof. Yael Haberman, MD, Associate Professor, Physician-Scientist & Head of Microbiome Center, Sheba Medical Center, “Mini-Gut” Organoids – Determining Causality & New Treatments”
Dr. Naomi Podeh Shakked, MD, PhD, Pediatric Nephrologist, Principal Investigator, Sourasky Medical Center, “Leveraging Human-Based Organoid Models to Decipher Disorders of Kidney Development”
Panel:
Limor Sandach, Healthcare Entrepreneur, Ex-CEO, AV Medical Technologies
Chen Ben-Dori, Co-Founder & CEO, OffRa Health
Dr. Tali Ilovitsh, Principal Investigator, Department of Biomedical Engineering, Tel Aviv University
Dr. Amir Minerbi, MD, PhD, Deputy Director, Rambam Institute for Pain Medicine
Closing: Shomrat Shurtz, Senior Director, Deputy Head of Growth Division, Lead of Health Tech Sector, Israel Innovation Authority
HALL B
14:30 - 16:30
Israeli medical science and technology breakthrough contributions to medicine
Moderators: Ruti Alon, CEO, Medstrada
Dr. Barak Azmon, MD, Founder, Journey1
Company Presenter:
Michael Kardosh, COO, Bionaut Labs, “Bionaut Labs – Revolutionizing Drug Delivery to the Brain”
Boaz Shlevin, Chief Product Officer, Pheno.AI, “We generate, organize, analyze and make accessible the world’s deepest-phenotype multi-omics datasets”
Prof. Ofra Benny, PhD, Professor in Pharmaceutical Sciences, Harry W. and Charlotte Ullman Labov Chair in Cancer Studies, Director, Fraunhofer Innovation Platform (FIP_DD@HUJI), Institute for Drug Research, The School of Pharmacy, Faculty of Medicine | Ein Karem Campus, The Hebrew University of Jerusalem, ” CultivO2 – Tissue Engineering in a green playground”
Haim Belinson, CEO, Bsense Bio Therapeutics, “Dual Ion channel Modulation, a Novel Mechanism for Treatment of Pain”
Prof. Yael Mardor, Chief Scientist, the Advanced Technology Center, Sheba Medical Center, “Portus – pulsed electrical fields to disrupt the blood-brain barrier”
Rachel Diamant, CEO, Cellergy, “Energizing cells: the future of mitochondrial medicine”
Almog Aley Raz, Co-Founder, CEO & VP R&D, CorNeat Vision, “Domesticating Foreign Body Response Around Implants”
Dr. David Smadja, Co-Founder & CEO, Nano Drops, ” NanoDrops, the new visual Botox for restoring vision”
Ravit Netzer, PhD, Co-Founder & CEO, Scala Biodesign, “Powering Therapeutics with Computational Protein Design”
Prof. Yonina Eldar, Professor, Department of Mathematics & Computer Science, Weizmann Institute, “The role of Radar technology in drug delivery & non-contact monitoring of vital signs”
Prof. Dror Harats, MD, CEO, ImmuneWalk Therapeutics, “New biology translated to innovative therapy”
Liron Rosenbaum, VP Strategy, Nova-Sight,
“TrackSight™ Software Based Myopia Prevention”
Shane Wald Altman, PhD, CEO, QRGenetics,
